The Newsroom
Item 1 of 3
AdventHealth Among First in U.S. to Offer IDP023-2-101 Clinical Trial for Patients with Progressive Multiple Sclerosis
The AdventHealth Neuroscience Institute is the first in Florida and one of the first in the country to begin recruiting patients with primary progressive or non-active secondary progressive multiple...
Item 2 of 3
AdventHealth Research Contributed to New Method for Tracking Diet and Its Impacts on Human Health
Item 3 of 3
Mayor Demings, AdventHealth on bridging health care gaps
Recent Stories at AdventHealthMD
-
-
Transcriptomic Immune Profiling: A Precision Path Forward for Immunotherapy in Patients with Cervical Cancer?
-
Multidisciplinary Pilot Program Aims to Improve Cardiovascular Health in Women with Adverse Pregnancy Outcomes
-
Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery in Cervical Cancers Size 2-4 cm: Emerging Data and Future Perspectives
-
Isolated Vulvar Langerhans Cell Histiocytosis
-
AdventHealth Physician Research Highlights Need for Genetic Testing to Target Non-Small-Cell Lung Cancer Treatment
-
Comparison of Myeloablative versus Reduced-intensity Conditioning Regimens in Allogeneic Stem Cell Transplantation Recipients with Acute Myelogenous Leukemia with Measurable Residual Disease-Negative Disease at the Time of Transplantation: A Retrospective
-
AdventHealth First in Central Florida to Offer Movement Disorder Patients Access to NeuroSphere Virtual Clinic for Remote Adjustment of Neurostimulation Devices